Youssef Fadia S, Singab Abdel Nasser B
Department of Pharmacognosy, Faculty of Pharmacy, Ain-Shams University, Cairo 11566, Egypt.
Center for Drug Discovery Research and Development, Faculty of Pharmacy, Ain-Shams University, Cairo 11566, Egypt.
Evid Based Complement Alternat Med. 2021 Jan 31;2021:8860784. doi: 10.1155/2021/8860784. eCollection 2021.
The secondary metabolites and biological activities of and were comprehensively reported. About 70 compounds were isolated from both species that belong to different classes using conventional and advanced chromatographic techniques and unambiguously elucidated employing one- and two-dimensional nuclear magnetic resonance (1D and 2D NMR) and high resolution mass spectrometry (HRMS). Some of them displayed promising antiviral, anti-inflammatory, and antioxidant activities. studies were conducted on human cyclin-dependent kinase 2 (CDK-2), human DNA topoisomerase II (TOP-2), and matrix metalloprotinase 13 (MMP-13) in an effort to explore the cytotoxic potential of the diverse compounds obtained from both species. 1,6,8-Trihydroxy-4-benzoyloxy-3-methylanthraquinone (23) revealed the most firm fitting with the active pockets of CDK-2 and MMP-13; meanwhile, variecolorin H alkaloid (14) showed the highest fitting within TOP-2 with ∆G equals to -36.51 kcal/mole. Thus, fungal metabolites could offer new drug entities for combating cancer. Relevant data about both species up to August 2020 were gathered from various databases comprising Scifinder (https://scifinder.cas.org/scifinder/login) for secondary metabolite-related studies; meanwhile, for biology-related articles, data were collected from both PubMed (http://www.ncbi.nlm.nih.gov/pubmed/) and Web of Knowledge (http://www.webofknowledge.com) as well.
对[两种物种名称未给出]的次生代谢产物和生物活性进行了全面报道。使用传统和先进的色谱技术从这两个属于不同类别的物种中分离出约70种化合物,并通过一维和二维核磁共振(1D和2D NMR)以及高分辨率质谱(HRMS)对其进行了明确鉴定。其中一些化合物显示出有前景的抗病毒、抗炎和抗氧化活性。对人细胞周期蛋白依赖性激酶2(CDK - 2)、人DNA拓扑异构酶II(TOP - 2)和基质金属蛋白酶13(MMP - 13)进行了研究,以探索从这两种[物种名称未给出]物种中获得的各种化合物的细胞毒性潜力。1,6,8 - 三羟基 - 4 - 苯甲酰氧基 - 3 - 甲基蒽醌(23)与CDK - 2和MMP - 13的活性口袋显示出最紧密的契合;同时,变色菌素H生物碱(14)在TOP - 2中显示出最高的契合度,自由能变化(∆G)等于 - 36.51千卡/摩尔。因此,真菌代谢产物可为抗癌提供新的药物实体。截至2020年8月,从包括Scifinder(https://scifinder.cas.org/scifinder/login)在内的各种数据库收集了有关这两种[物种名称未给出]物种的次生代谢产物相关研究的相关数据;同时,对于生物学相关文章,数据也从PubMed(http://www.ncbi.nlm.nih.gov/pubmed/)和Web of Knowledge(http://www.webofknowledge.com)收集。